SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: forgetme5/12/2025 3:00:40 PM
1 Recommendation

Recommended By
erippetoe

   of 63284
 
ctmx

  • abbv met adc data medium 3rd line pts were not as sick
    Efficacy:
    • ORR: 18% at 2.4 mg/kg and 24% at 3.0 mg/kg.

    • ORR in high c-Met expression: >35% at doses =2.4 mg/kg.

    • Median duration of response: 5.5 months (95% CI, 4.1–not evaluable).

    • 12-week CBR: 50%.

    • 24-week CBR: 29%.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News